Clinical Advances Driving Growth in the Overt Hepatic Encephalopathy Market According to a newly published market research report by 24LifeSciences, the global overt hepatic encephalopathy market was valued at USD 53.1 million in 2026 and is projected to reach USD 84 million by 2034, growing at a compound annual growth rate (CAGR) of 6.9% during the forecast period. Overt Hepatic Encephalopathy (OHE), the clinically apparent manifestation of Hepatic Encephalopathy, is a serious neuropsychiatric syndrome that occurs as a complication of liver failure. It spans a spectrum of neurological impairments from subtle cognitive deficits to severe alterations in consciousness, personality changes, and motor disturbances. Left untreated, the condition can progress to coma and is associated with significant morbidity and mortality, underscoring its critical importance in hepatology and critical care medicine. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/9573/overt-hepatic-encephalopathy-market